empower pharmacy glp-1 Access Agonists Semaglutide / Cyanocobalamin Injection |
Description
Retatrutide vs Semaglutide: Evidence-based comparison of the investigational triple GIP/GLP-1/glucagon agonist versus the FDA-approved GLP-1 agonist
Very few include older adults at high risk
Health and wellness company Hims & Hers announced Monday that it is introducing injectable weight-loss drugs at a fraction of the cost of Ozempic and Wegovy.
Closing the wealth gap in GLP-1 access
Intention-to-treat analyses resulted in an HR of 1.36 (95% CI 0.51, 3.61)
While this medication absolutely has its place, Im increasingly concerned when I see people not just losing weight but also losing muscle mass
